Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00090818 · ClinicalTrials.gov registry record

Clinical Research Core Dental Screening Protocol

A clinical trial, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).

Completed
Registry status
441
Enrollment target

NCT00090818: Completed study, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).

NCT00090818 is a clinical trial that has completed, run by National Institute of Dental and Craniofacial Research (NIDCR). The registered enrollment target is 441 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00090818 has completed, sponsored by National Institute of Dental and Craniofacial Research (NIDCR).

COMPLETED
Registry status
441 participants
Enrollment target

Study Summary

This study will screen patients for eligibility in studies sponsored by the Craniofacial Genetics Section (HCGS), the Clinical Research Core (CRC), and other branches located within the National Institute of Dental and Craniofacial Research (NIDCR). It will also evaluate patients with diseases or abnormalities of the oral cavity or craniofacial complex, or both, for future protocol development. HCGS and CRC study the natural history of oral diseases and systemic diseases that are manifested in the maxillofacial region-the upper jaw and face. Among the diseases are lichen planus, systemic lupus erythematosus, and premalignant oral leukoplakia. Researchers also study certain acquired diseases and genetic diseases. Because many of the diseases of the maxillofacial region are poorly defined, the evaluation and characterization of patients with such diseases are goals of investigation. Patients of any age, gender, and racial and ethnic group who have oral diseases or systemic diseases of the upper jaw and face may be eligible for the study. Women of childbearing potential, or who are pregnant or lactating, may be eligible; they would undergo procedures and tests or receive medications posing a minimal risk to the fetus or child. Participants will undergo the following procedures: * Complete medical history and physical examination, including a thorough examination of the head and neck; detailed examination of the teeth and gums may or may not be necessary. * Tests of blood, urine, stool; tests for pregnancy and HIV when needed; and tests for cultures, fungi, bacteria, and parasites. * Sampling of blood and oral tissues for diagnosis, treatment response, and disease progression. * Electrocardiogram, x-ray, and imaging procedures, including imaging of the face. Biopsies may be performed as needed for diagnosis and to guide therapy. The type, number, location, and frequency of biopsies depend on several factors, including the nature of the disease being evaluated. Local

Trial Details

FieldValue
Enrollment Target 441 participants
Start Date 2004-09-01
Est. Completion 2010-10-28

What the finished NCT00090818 record still lists

NCT00090818 is an observational study that tracks outcomes without assigning an intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00090818 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00090818 about?

NCT00090818 is a clinical study titled "Clinical Research Core Dental Screening Protocol". This study will screen patients for eligibility in studies sponsored by the Craniofacial Genetics Section (HCGS), the Clinical Research Core (CRC), and other branches located within the National Institute of Dental and Craniofacial Research (NIDCR). It will also evaluate patients with diseases or ab...

What is the current status of trial NCT00090818?

This trial is currently completed. The enrollment target is 441 participants. The study started on 2004-09-01. Estimated completion is 2010-10-28.

Who is sponsoring clinical trial NCT00090818?

This trial is sponsored by National Institute of Dental and Craniofacial Research (NIDCR), which has 91 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02679144 · 441 participants · Phase 2

    Neuroblastoma Maintenance Therapy Trial

  • NCT03704766 · 442 participants · NA

    Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

  • NCT04657068 · 442 participants · Phase 1

    A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • NCT05410145 · 442 participants · Phase 1

    A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00090818, the US trial registry maintained by the National Library of Medicine. NCT00090818 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.